Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Morabito A, Piccirillo MC, Maione P, Luciani A, Cavanna L, Bonanno L, Filipazzi V, Leo S, Cinieri S, Morgillo F, Burgio MA, Ferrara D, Rosetti F, Bianco R, Artioli F, Cortinovis D, Gebbia V, Fregoni V, Mencoboni M, Sandomenico C, Rossi A, Montanino A, Manzo A, Rocco G, Arenare L, Daniele G, Signoriello S, Gallo C, Perrone F, Gridelli C.

Lung Cancer. 2019 Jul;133:62-68. doi: 10.1016/j.lungcan.2019.05.009. Epub 2019 May 9.

PMID:
31200830
2.

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial.

Perrone F, De Laurentiis M, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Tinessa V, Mosconi AM, Nuzzo F, Di Rella F, Gravina A, Iodice G, Landi G, Pacilio C, Forestieri V, Lauria R, Fabbri A, Ibrahim T, De Maio E, Barni S, Gori S, Simeon V, Arenare L, Daniele G, Piccirillo MC, Normanno N, de Matteis A, Gallo C.

Eur J Cancer. 2019 Jun 1. pii: S0959-8049(19)30297-7. doi: 10.1016/j.ejca.2019.05.004. [Epub ahead of print]

PMID:
31164265
3.

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.

Daniele G, Arenare L, Scambia G, Pisano C, Sorio R, Breda E, De Placido S, Savarese A, Ferrandina G, Raspagliesi F, Panici PB, Ferro A, Rimanti A, Cormio G, Lorusso D, Cecere SC, Scalone S, Marsico VA, Cardalesi C, Cognetti F, Salutari V, Attademo L, Guizzaro L, Schettino C, Piccirillo MC, Perrone F, Gallo C, Pignata S.

Gynecol Oncol. 2019 Jul;154(1):83-88. doi: 10.1016/j.ygyno.2019.04.012. Epub 2019 Apr 24.

PMID:
31029508
4.

Does water temperature influence the distribution and elimination of perfluorinated substances in rainbow trout (Oncorhynchus mykiss)?

Vidal A, Lafay F, Daniele G, Vulliet E, Rochard E, Garric J, Babut M.

Environ Sci Pollut Res Int. 2019 Jun;26(16):16355-16365. doi: 10.1007/s11356-019-05029-w. Epub 2019 Apr 13.

PMID:
30980373
5.

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.

Pignata S, Scambia G, Lorusso D, De Giorgi U, Nicoletto MO, Lauria R, Mosconi AM, Sacco C, Omarini C, Tagliaferri P, Ferrandina G, Cinieri S, Savarese A, Valabrega G, Pisano C, Salutari V, Raspagliesi F, Kopf B, Cecere SC, Amadio G, Maltese G, Di Napoli M, Greggi S, Signoriello S, Daniele G, Sacco A, Losito S, Normanno N, Perrone F, Gallo C, Piccirillo MC; MITO Investigators.

Gynecol Oncol. 2019 Jun;153(3):535-540. doi: 10.1016/j.ygyno.2019.03.260. Epub 2019 Apr 9.

PMID:
30979589
6.

Exenatide modulates visual cortex responses.

Binda P, Eldor R, Huerta C, Adams J, Lancaster J, Fox P, Del Prato S, DeFronzo R, Abdul-Ghani M, Daniele G.

Diabetes Metab Res Rev. 2019 Apr 11:e3167. doi: 10.1002/dmrr.3167. [Epub ahead of print]

PMID:
30974038
7.

1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.

Daniele G, L'Abbate A, Turchiano A, Palumbo O, Carella M, Lo Cunsolo C, Iuzzolino P, Lonoce A, Hernández-Sánchez M, Minoia C, Leone P, Hernandez-Rivas JM, Storlazzi CT.

Clin Exp Med. 2019 May;19(2):261-267. doi: 10.1007/s10238-019-00551-0. Epub 2019 Mar 15.

PMID:
30877410
8.

Comparison in the response of three European Gammarid species exposed to the growth regulator insecticide fenoxycarb.

Arambourou H, Vulliet E, Daniele G, Noury P, Delorme N, Abbaci K, Forcellini M, Tutundjian R, Barata C.

Environ Sci Pollut Res Int. 2019 Apr;26(11):11496-11502. doi: 10.1007/s11356-019-04631-2. Epub 2019 Mar 12.

PMID:
30864032
9.

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.

Giusti R, Mazzotta M, Filetti M, Daniele G, Tsukuura H, Ficorella C, Porzio G, Marchetti P, Verna L.

Support Care Cancer. 2019 Jan 26. doi: 10.1007/s00520-019-4663-1. [Epub ahead of print]

PMID:
30684048
10.

Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus.

Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, Dauriz M, Dotta F, Formichi C, Frontoni S, Invitti C, Orsi E, Picconi F, Resi V, Bonora E, Purrello F.

Acta Diabetol. 2019 Jun;56(6):605-617. doi: 10.1007/s00592-018-1271-3. Epub 2019 Jan 2. Review.

PMID:
30603867
11.

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, Burgio MA, Bilancia D, Cortinovis D, Rosetti F, Bianco R, Gebbia V, Artioli F, Bordonaro R, Fregoni V, Mencoboni M, Nelli F, Riccardi F, di Isernia G, Costanzo R, Rocco G, Daniele G, Signoriello S, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2018 Sep 1;36(25):2585-2592. doi: 10.1200/JCO.2017.76.8390. Epub 2018 Jul 20.

PMID:
30028656
12.

Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences.

L'Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, Squeo G, D'Addabbo P, Traversa D, Daniele G, Lonoce A, Pafundi M, Carella M, Palumbo O, Dolnik A, Muehlematter D, Schoumans J, Van Roy N, De Bellis G, Martinelli G, Merla G, Bullinger L, Haferlach C, Storlazzi CT.

Leukemia. 2018 Oct;32(10):2304. doi: 10.1038/s41375-018-0177-y.

PMID:
29985446
13.

Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.

Lucchesi D, Popa SG, Sancho V, Giusti L, Garofolo M, Daniele G, Pucci L, Miccoli R, Penno G, Del Prato S.

Cardiovasc Diabetol. 2018 Jun 5;17(1):78. doi: 10.1186/s12933-018-0720-1.

14.

Development of a method for the simultaneous determination of multi-class pesticides in earthworms by liquid chromatography coupled to tandem electrospray mass spectrometry.

Daniele G, Lafay F, Pelosi C, Fritsch C, Vulliet E.

Anal Bioanal Chem. 2018 Aug;410(20):5009-5018. doi: 10.1007/s00216-018-1151-2. Epub 2018 Jun 4.

PMID:
29862430
15.

Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.

Garofolo M, Russo E, Miccoli R, Lucchesi D, Giusti L, Sancho-Bornez V, Daniele G, Del Prato S, Penno G.

J Diabetes Complications. 2018 Jun;32(6):550-557. doi: 10.1016/j.jdiacomp.2018.03.012. Epub 2018 Apr 3.

PMID:
29705091
16.

Fenoxycarb exposure disrupted the reproductive success of the amphipod Gammarus fossarum with limited effects on the lipid profile.

Arambourou H, Fuertes I, Vulliet E, Daniele G, Noury P, Delorme N, Abbaci K, Barata C.

PLoS One. 2018 Apr 27;13(4):e0196461. doi: 10.1371/journal.pone.0196461. eCollection 2018.

17.

MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences.

L'Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, Squeo G, D'Addabbo P, Traversa D, Daniele G, Lonoce A, Pafundi M, Carella M, Palumbo O, Dolnik A, Muehlematter D, Schoumans J, Van Roy N, De Bellis G, Martinelli G, Merla G, Bullinger L, Haferlach C, Storlazzi CT.

Leukemia. 2018 Oct;32(10):2152-2166. doi: 10.1038/s41375-018-0033-0. Epub 2018 Feb 22. Erratum in: Leukemia. 2018 Jul 9;:.

18.

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

Piccirillo MC, Scambia G, Bologna A, Signoriello S, Vergote I, Baumann K, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Gallo C, Pignata S, Perrone F.

Ann Oncol. 2018 May 1;29(5):1189-1194. doi: 10.1093/annonc/mdy062.

PMID:
29462248
19.

Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.

Al Jobori H, Daniele G, Adams J, Cersosimo E, Solis-Herrera C, Triplitt C, DeFronzo RA, Abdul-Ghani M.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1402-1407. doi: 10.1210/jc.2017-01838.

PMID:
29342295
20.

MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences.

ĹAbbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, Squeo G, D Addabbo P, Traversa D, Daniele G, Lonoce A, Pafundi M, Carella M, Palumbo O, Dolnik A, Muehlematter D, Schoumans J, Van Roy N, De Bellis G, Martinelli G, Merla G, Bullinger L, Haferlach C, Storlazzi CT.

Leukemia. 2017 Nov 28. doi: 10.1038/leu.2017.337. [Epub ahead of print]

PMID:
29180669
21.

The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.

Daniele G, Winnier D, Mari A, Bruder J, Fourcaudot M, Pengou Z, Hansis-Diarte A, Jenkinson C, Tripathy D, Folli F.

Acta Diabetol. 2018 Feb;55(2):139-148. doi: 10.1007/s00592-017-1065-z. Epub 2017 Nov 18.

22.

Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line.

Sancho V, Daniele G, Lucchesi D, Lupi R, Ciccarone A, Penno G, Bianchi C, Dardano A, Miccoli R, Del Prato S.

PLoS One. 2017 Nov 9;12(11):e0187836. doi: 10.1371/journal.pone.0187836. eCollection 2017.

23.

Angiogenesis Inhibitors in NSCLC.

Manzo A, Montanino A, Carillio G, Costanzo R, Sandomenico C, Normanno N, Piccirillo MC, Daniele G, Perrone F, Rocco G, Morabito A.

Int J Mol Sci. 2017 Sep 21;18(10). pii: E2021. doi: 10.3390/ijms18102021. Review.

24.

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.

Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2017 Oct 10;35(29):3347-3353. doi: 10.1200/JCO.2017.73.4293. Epub 2017 Aug 21.

PMID:
28825853
25.

Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter].

Penno G, Russo E, Garofolo M, Daniele G, Lucchesi D, Giusti L, Sancho Bornez V, Bianchi C, Dardano A, Miccoli R, Del Prato S.

Diabetologia. 2017 Oct;60(10):2123-2125. doi: 10.1007/s00125-017-4387-z. Epub 2017 Aug 2. No abstract available.

PMID:
28770329
26.

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.

Morabito A, Daniele G, Costanzo R, Favaretto AG, Filipazzi V, Rossi A, Gebbia V, Castiglione F, Cavanna L, Maiello E, Sandomenico C, Bonanno L, Piazza E, Maione P, Piccirillo MC, Di Maio M, Rocco G, Gallo C, Perrone F, Gridelli C.

Lung Cancer. 2017 Jun;108:15-21. doi: 10.1016/j.lungcan.2017.02.016. Epub 2017 Feb 27.

PMID:
28625627
27.

Phenotypic defects in newborn Gammarus fossarum (Amphipoda) following embryonic exposure to fenoxycarb.

Arambourou H, Chaumot A, Vulliet E, Daniele G, Delorme N, Abbaci K, Debat V.

Ecotoxicol Environ Saf. 2017 Oct;144:193-199. doi: 10.1016/j.ecoenv.2017.06.017. Epub 2017 Jun 14.

PMID:
28623797
28.

Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.

Abdul-Ghani M, Al Jobori H, Daniele G, Adams J, Cersosimo E, Triplitt C, DeFronzo RA.

Diabetes. 2017 Sep;66(9):2495-2502. doi: 10.2337/db17-0055. Epub 2017 Jun 13.

29.

Determination of carbamazepine and 12 degradation products in various compartments of an outdoor aquatic mesocosm by reliable analytical methods based on liquid chromatography-tandem mass spectrometry.

Daniele G, Fieu M, Joachim S, Bado-Nilles A, Beaudouin R, Baudoin P, James-Casas A, Andres S, Bonnard M, Bonnard I, Geffard A, Vulliet E.

Environ Sci Pollut Res Int. 2017 Jul;24(20):16893-16904. doi: 10.1007/s11356-017-9297-6. Epub 2017 Jun 2.

PMID:
28573566
30.

Determination of a new index of sexual maturity (ISM) in zebra mussel using flow cytometry: interest in ecotoxicology.

Magniez G, Franco A, Geffard A, Rioult D, Bonnard I, Delahaut L, Joachim S, Daniele G, Vulliet E, Porcher JM, Bonnard M.

Environ Sci Pollut Res Int. 2018 Apr;25(12):11252-11263. doi: 10.1007/s11356-017-9256-2. Epub 2017 May 31.

PMID:
28567680
31.

Exposure assessment of honeybees through study of hive matrices: analysis of selected pesticide residues in honeybees, beebread, and beeswax from French beehives by LC-MS/MS.

Daniele G, Giroud B, Jabot C, Vulliet E.

Environ Sci Pollut Res Int. 2018 Mar;25(7):6145-6153. doi: 10.1007/s11356-017-9227-7. Epub 2017 May 30.

PMID:
28560623
32.

Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes.

Al-Jobori H, Daniele G, Cersosimo E, Triplitt C, Mehta R, Norton L, DeFronzo RA, Abdul-Ghani M.

Diabetes. 2017 Jul;66(7):1999-2006. doi: 10.2337/db17-0100. Epub 2017 Apr 20.

33.

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells.

Daniele G, Simonetti G, Fusilli C, Iacobucci I, Lonoce A, Palazzo A, Lomiento M, Mammoli F, Marsano RM, Marasco E, Mantovani V, Quentmeier H, Drexler HG, Ding J, Palumbo O, Carella M, Nadarajah N, Perricone M, Ottaviani E, Baldazzi C, Testoni N, Papayannidis C, Ferrari S, Mazza T, Martinelli G, Storlazzi CT.

Haematologica. 2017 Jul;102(7):1204-1214. doi: 10.3324/haematol.2016.163022. Epub 2017 Apr 14.

34.

Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.

Penno G, Russo E, Garofolo M, Daniele G, Lucchesi D, Giusti L, Sancho Bornez V, Bianchi C, Dardano A, Miccoli R, Del Prato S.

Diabetologia. 2017 Jun;60(6):1102-1113. doi: 10.1007/s00125-017-4251-1. Epub 2017 Mar 29.

PMID:
28357502
35.

Water safety in healthcare facilities. The Vieste Charter.

Bonadonna L, Cannarozzi de Grazia M, Capolongo S, Casini B, Cristina ML, Daniele G, D'Alessandro D, De Giglio O, Di Benedetto A, Di Vittorio G, Ferretti E, Frascolla B, La Rosa G, La Sala L, Lopuzzo MG, Lucentini L, Montagna MT, Moscato U, Pasquarella C, Prencipe R, Ricci ML, Romano Spica V, Signorelli C, Veschetti E.

Ann Ig. 2017 Mar-Apr;29(2):92-100. doi: 10.7416/ai.2017.2136.

36.

Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes.

Bianchi C, Daniele G, Dardano A, Miccoli R, Del Prato S.

Drugs. 2017 Mar;77(3):247-264. doi: 10.1007/s40265-017-0694-4. Review.

PMID:
28155046
37.

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients.

Al Jobori H, Daniele G, Adams J, Cersosimo E, Triplitt C, DeFronzo RA, Abdul-Ghani M.

Diabetes Obes Metab. 2017 Jun;19(6):809-813. doi: 10.1111/dom.12881. Epub 2017 Mar 27.

PMID:
28128510
38.

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.

Daniele G, Lorusso D, Scambia G, Cecere SC, Nicoletto MO, Breda E, Colombo N, Artioli G, Cannella L, Lo Re G, Raspagliesi F, Maltese G, Salutari V, Ferrandina G, Greggi S, Baldoni A, Bergamini A, Piccirillo MC, Tognon G, Floriani I, Signoriello S, Perrone F, Pignata S.

Gynecol Oncol. 2017 Feb;144(2):256-259. doi: 10.1016/j.ygyno.2016.12.011. Epub 2016 Dec 16.

PMID:
27993479
39.

Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytes.

Shannon CE, Daniele G, Galindo C, Abdul-Ghani MA, DeFronzo RA, Norton L.

FEBS J. 2017 Feb;284(3):451-465. doi: 10.1111/febs.13992. Epub 2017 Jan 18.

40.

Rapid weight gain in professional boxing and correlation with fight decisions: analysis from 71 title fights.

Daniele G, Weinstein RN, Wallace PW, Palmieri V, Bianco M.

Phys Sportsmed. 2016 Nov;44(4):349-354. Epub 2016 Sep 6. Erratum in: Phys Sportsmed. 2016 Nov;44(4):vii.

PMID:
27564844
41.

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.

Perrone F, Jommi C, Di Maio M, Gimigliano A, Gridelli C, Pignata S, Ciardiello F, Nuzzo F, de Matteis A, Del Mastro L, Bryce J, Daniele G, Morabito A, Piccirillo MC, Rocco G, Guizzaro L, Gallo C.

Ann Oncol. 2016 Dec;27(12):2224-2229. doi: 10.1093/annonc/mdw433. Epub 2016 Oct 26.

PMID:
27789469
42.

Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.

Gastaldelli A, Gaggini M, Daniele G, Ciociaro D, Cersosimo E, Tripathy D, Triplitt C, Fox P, Musi N, DeFronzo R, Iozzo P.

Hepatology. 2016 Dec;64(6):2028-2037. doi: 10.1002/hep.28827.

PMID:
27639082
43.

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.

Daniele G, Xiong J, Solis-Herrera C, Merovci A, Eldor R, Tripathy D, DeFronzo RA, Norton L, Abdul-Ghani M.

Diabetes Care. 2016 Nov;39(11):2036-2041. Epub 2016 Aug 25.

44.

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.

Eldor R, Daniele G, Huerta C, Al-Atrash M, Adams J, DeFronzo R, Duong T, Lancaster J, Zirie M, Jayyousi A, Abdul-Ghani M.

Diabetes Care. 2016 Oct;39(10):1804-10. doi: 10.2337/dc15-2706. Epub 2016 Aug 3.

45.

Development of a multi-residue analysis of diclofenac and some transformation products in bivalves using QuEChERS extraction and liquid chromatography-tandem mass spectrometry. Application to samples from mesocosm studies.

Daniele G, Fieu M, Joachim S, James-Casas A, Andres S, Baudoin P, Bonnard M, Bonnard I, Geffard A, Vulliet E.

Talanta. 2016 Aug 1;155:1-7. doi: 10.1016/j.talanta.2016.04.016. Epub 2016 Apr 8.

PMID:
27216649
46.

BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Gridelli C, Rossi A, Ciardiello F, De Marinis F, Crinò L, Morabito A, Morgillo F, Montanino A, Daniele G, Piccirillo MC, Normanno N, Gallo C, Perrone F.

Clin Lung Cancer. 2016 Sep;17(5):461-465. doi: 10.1016/j.cllc.2016.04.001. Epub 2016 Apr 22.

PMID:
27209164
47.

Detection and quantification of boscalid and its metabolites in honeybees.

Jabot C, Daniele G, Giroud B, Tchamitchian S, Belzunces LP, Casabianca H, Vulliet E.

Chemosphere. 2016 Aug;156:245-251. doi: 10.1016/j.chemosphere.2016.04.135. Epub 2016 May 11.

PMID:
27179242
48.

Rapid analysis of diclofenac and some of its transformation products in the three-spined stickleback, Gasterosteus aculeatus, by liquid chromatography-tandem mass spectrometry.

Daniele G, Fieu M, Joachim S, Bado-Nilles A, Baudoin P, Turies C, Porcher JM, Andres S, Vulliet E.

Anal Bioanal Chem. 2016 Jun;408(16):4435-44. doi: 10.1007/s00216-016-9541-9. Epub 2016 Apr 16.

PMID:
27086017
49.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A.

BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y.

50.

Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males.

Merovci A, Abdul-Ghani M, Mari A, Solis-Herrera C, Xiong J, Daniele G, Tripathy D, DeFronzo RA.

J Clin Endocrinol Metab. 2016 Mar;101(3):1249-56. doi: 10.1210/jc.2015-2597. Epub 2016 Jan 14.

Supplemental Content

Loading ...
Support Center